EntryPoint Capital’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,876
Closed -$74.7K 1225
2024
Q2
$74.7K Buy
+8,876
New +$94.6K 0.11% 426
2024
Q1
Sell
-1,787
Closed -$38.5K 1819
2023
Q4
$38.5K Buy
+1,787
New +$31.9K 0.04% 843

Other funds holding NVRO

EntryPoint Capital's NVRO Position: Q3 2024 in Review

EntryPoint Capital sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 8,876 shares — an estimated $74.7K sold.

EntryPoint Capital first reported a position in NVRO in Q4 2023 and held it in 2 quarters. The position peaked at $74.7K in Q2 2024. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • EntryPoint Capital reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • EntryPoint Capital sold 8,876 NEVRO CORP. shares in Q3 2024, an estimated $74.7K.
  • EntryPoint Capital first reported a position in NEVRO CORP. in Q4 2023 and held it in 2 quarters.
  • EntryPoint Capital's NEVRO CORP. position peaked at $74.7K in Q2 2024.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.